Back to search

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics

Data up to Jan 2025

Published2004
Citations377
References19

Total Citations Per Year

Abstract

References (19)

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

1998 • 14,674 citations

Tumor Angiogenesis: Therapeutic Implications

1971 • 9,898 citations

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

2001 • 9,275 citations

Angiogenesis in cancer, vascular, rheumatoid and other disease

1995 • 7,717 citations

Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen

1989 • 4,988 citations

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1993 • 3,605 citations

VEGF-Trap: A VEGF blocker with potent antitumor effects

2002 • 1,641 citations

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

2003 • 1,236 citations

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

2003 • 1,172 citations

Analysis of gene function in somatic mammalian cells using small interfering RNAs

2002 • 1,108 citations

Angiogenesis and Tumor Metastasis

1998 • 1,013 citations

Placental Growth Factor, a Member of the VEGF Family, Contributes to the Development of Choroidal Neovascularization

2003 • 315 citations

Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.

2000 • 309 citations

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.

1996 • 239 citations

New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet

1999 • 232 citations

Expression of VEGF‐C and VEGF‐D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma

2004 • 151 citations

Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.

2001 • 141 citations

Atelocollagen-Based Gene Transfer in Cells Allows High-Throughput Screening of Gene Functions

2001 • 80 citations

5′-,3′-Inverted Thymidine-modified Antisense Oligodeoxynucleotide Targeting Midkine

2002 • 50 citations

Cited By (0)

No citing papers found in database

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer… (2004) – Cancer Research | Metascience Observatory Explorer